Structural Characterization of Inhibitor Complexes with Checkpoint Kinase 2 (Chk2), a Drug Target for Cancer Therapy

Chk2 (checkpoint kinase 2) is a serine/threonine kinase that participates in a series of signaling networks responsible for maintaining genomic integrity and responding to DNA damage. The development of selective Chk2 inhibitors has recently attracted much interest as a means of sensitizing cancer c...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Lountos, George T., Jobson, Andrew G., Tropea, Joseph E., Self, Christopher R., Zhang, Guangtao, Pommier, Yves, Shoemaker, Robert H., Waugh, David S.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2011
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3210331/
https://ncbi.nlm.nih.gov/pubmed/21963792
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jsb.2011.09.008
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky